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Abstract
Introduction The osteopathology of the jaws associated
with bone resorption inhibitors is a current topic that
engages a variety of clinical specialists. This has increased
after the approval of denosumab for treatment of osteopo-
rosis and skeletal-related events in patients with solid ma-
lignancy. Early after the first publications, there is a possible
connection between phosphorous necrosis of the jaws, a
dreadful industrial disease mentioned, and bisphosphonate-
induced pathology. The nineteenth century was the prime
time for phosphorus necrosis of match factory workers.
Results This occurrence provides an interesting insight into
the medical and surgical profession in the nineteenth centu-
ry. There are striking parallels and repetition of current and
old ideas in the approach to this “new disease.” There are
similar examples in case descriptions when compared with
today’s patients of bisphosphonate-related osteonecrosis of
the jaws (BRONJ).
Discussion Phosphorus necrosis was first described in Aus-
tria. Soon after this, surgeons in German-speaking countries
including well-known clinicians Wegner (1872) and von
Schulthess-Rechberg (1879) pioneered the analysis, preven-
tative measures, and treatment of this disease. The tendency
at this time was to approach BRONJ as a “special kind of
osteomyelitis” in pretreated and metabolically different
bone. Not only the treatment strategy to wait until seques-
trum formation with subsequent removal and preventative
measures but also the idea of focusing on the periosteum as
the triggering anatomical structure may have been adopted
from specialists in the nineteenth century. Therefore,
phosphorous necrosis of the jaw is an excellent example of
“learning from the past.”
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Introduction
Since 2003, clinicians have been dealing with a new type of
bone pathology that involves the upper and lower jaw:
bisphosphonate-related osteonecrosis of the jaws (ONJ)
[1]. Today, it is known as a multifactorial disease associated
with bone resorption inhibition therapy and with a local
triggering factor in most cases. It is clinically usually repre-
sented by exposed bone predominantly in the mandibular
molar area [2]. Shortly after discovery, the first reports
emerged reporting on the similarity of bisphosphonate-
related osteonecrosis of the jaws (BRONJ) and a previously
well-known disease called phosphorous necrosis of the jaw
(PNJ) [3]. The workers in match factories, firework produc-
tion companies, and factories producing munitions with
white phosphorous were affected by PNJ. In 2008, R. Marx
demonstrated chemical conversion of phosphorous fumes
into bisphosphonates and “uncovered” BRONJ as a replace-
ment of phossy jaw [4]. But still, questions about phossy
and bisphossy jaw exist after looking back into the
nineteenth century with careful analysis of detailed reports
of cases, opening some interesting parallels.
The production of matches with white phosphorus in
German-speaking countries started in 1833. The first case
of PNJ was described soon afterwards in 1838 by Lorinser;
he named the disease “phosphorimus chronicus” [5]. Soon
afterwards, PNJ became an increasingly public and political
problem [6, 7]. The first official hearing on necessary con-
structive measures in match factories in Switzerland took
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place in 1841 in Zurich [8]. Finally, in 1906 in the Berne
Convention, the manufacture and importation of white
phosphorus was banned in several European countries, fol-
lowed by the USA in 1912 by passing the Match Act [9].
The aim of this article was to retrospectively review the
nineteenth century literature to detect and compare interest-
ing and striking parallels in dealing with a “new” disease
and learn from the past.
Material and methods
Patients
To analyze patients with PNJ, we referred to two detailed
case series from 1879 to 1893. The first document presented
55 patients with PNJ who were treated at the University
Hospital of Bern, beginning in 1867 with a mean follow-up
time of 12 years [10]. The second document gave a detailed
description of 12 patients with PNJ who were treated at the
University Hospital of Zurich, beginning in 1868 [11]. Pa-
tient data were compared with retrospectively analyzed data
of 110 patients with apparent ONJ who were treated and
followed up in the Department of Oral and Maxillofacial
Surgery, University of Zurich from 2005 until 2010. Sys-
temic factors, etiology, period and kind of drug regimen,
local risk factors, symptoms, clinical picture, treatment
methods, and response to treatment were carefully analyzed
and discussed according to the current knowledge on ONJ.
Literature search
From 2003, an ongoing literature search concerning both
ONJ and PNJ was performed. Electronic databases
(PubMed, OVID, MEDLINE, and NLM) were searched
using a set of predetermined keywords (“phosphorus necro-
sis,” “osteonecrosis of the jaws,” “bisphosphonates,”
“osteonecrosis,” and “match factory worker”). To find back
issues of case reports and reviews on PNJ, an extensive
search was performed in Swiss institutes of medical history
and libraries in German-speaking countries. Reference lists
of articles were additionally searched for any related
articles.
Results
Patients
Sixty-seven patients with PNJ were compared with 110 ONJ
patients. Descriptive statistics regarding the general infor-
mation and details of possible associated risk factors and
sites are displayed in Table 1.
Clinical picture
Most PNJ patients presented with pain or swelling. The
symptoms and clinical picture were described as a “special,
dangerous type of infection.” Kocher and von Schulthess-
Rechberg characterized this pain of as “persistent, yet pro-
gressive with spread to neighboring teeth and jawbone” in
contrast to pain of an ordinary infection [10]. Pus formation
usually developed and penetrated the skin or oral mucosa
with fistula formation, loss of teeth, and recurrent abscesses.
Progression persisted, even if the match factory worker was
detracted from the “harmful contact to phosphorous” with
sequestrum formation about 3 months and necrosis of partly
wide areas of the jaw about 6 months after appearance of the
first symptoms [10]. Another characteristic finding was
extensive periosteal reactions, described as “osteophytes”
[11]. The most dangerous area for PNJ was the maxilla with
possible spread of infection with subsequent meningitis and
death of the patient [12]. The exposed bone areas never
showed the entire extent of the lesion. “The disease course
was characterized by retraction of the periosteum and oral
mucosa extension of necrotic bone into the oral cavity” [11]
(Fig. 1). Table 1 summarizes the clinical picture of ONJ
patients.
Treatment
The majority of Kocher’s patients were treated surgically
with the intention of removal of infected bone and teeth to
eliminate the origin of the disease (Fig. 2a, b). A less
invasive method had been performed in Zurich at that time.
Demarcation of sequestra was the aim with subsequent
sequestrectomy and local revision or resection in all 12
cases without touching the periosteum and osteophytes.
Six of Kocher’s patients died due to direct consequences
of the disease or the surgical treatment. A mortality rate of
25 % (n03) and therefore a success rate of 75 % were
described by von Schulthess-Rechberg [11]. In 12 patients,
regeneration with growth of a neomandible was described.
Of all 110 patients with ONJ, 58 % were treated surgi-
cally; if possible, the procedure was minimally invasive
(sequestrectomy) after a drug holiday of 3 to 6 months.
All patients underwent additional systemic anti-infectious
therapy (Fig. 3a, b).
Discussion
Analysis of PNJ began in Austria (Vienna) with its first
mention in 1838, followed by an official publication by
Friedrich Wilhelm Lorinser in 1945 [5]. Phosphorous ne-
crosis was one of the most dreaded but accepted industrial
diseases, and the origins of many political measures and
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Table 1 Descriptive statistics of
patients with phossy jaw and
bisphossy jaw including general
factors, local risk factors, treat-
ment strategy, and outcome
aPatients may belong to more
than one group
bType of surgical treatment:
maxillectomy 13, hemimaxillec-
tomy 7, partial mandibular resec-
tion 12, hemimandibulectomy
7, mandibulectomy 10
c“Self-treatment”
mandibulectomy, 3
dThereof, six are due to
direct consequences of phospho-
rous necrosis
Kocher [10] von Schulthess-Rechberg [11] “Bisphossy” jaw
n055 n012 n0110
Gender, n (%)
M 19 2 33 (30)
F 36 10 77 (70)
Mean age (years) 30 31 67
Range (years) 18–50 19–40 37–94
Medication,a n (%)
Zoledronic acid 80 (73)
Pamidronate 18
Alendronate 14
Others 22
Underlying disease, n (%)
Malignant 83 (75)
Nonmalignant 27 (25)
Duration of work (months) 116 67
Range (months) 8–240 6–240
No information (n) 34
Duration of BP treatment (months) 35
Range (months) 3–120
Local risk factor, n (%)
Extraction 70 (64)
Prosthesis 18
Implantation 15
Other 22
Clinical presentation, n (%)
Pain 83 (75)
Pus 63
Abscess 28
Paresthesia 21
Exposed bone 81
Fistula 25
Involvement of sinus 14
Other 14
Localization, n (%)
Mandible 27 (55) 9 (75) 83 (75)
Maxilla 21 6 31
Both 2 3 4
No information 6
Treatment, n (%)
Surgical 46b (84) 9 (75) 64 (58)
“Self”-treatment 3c
Conservative 3 3 46
Dental extractions 2
No information 1
Outcome, n (%)
Complete remission 22 9 (75) 50 (78)
Death, n (%) 10d (45) 3 (25)
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laws concerning working conditions and child labor were
associated with this disease. Notably, in 1845, about 50 years
before the invention of antibiotics, cure of infectious dis-
eases was often unsuccessful and time consuming.
Today, severity of infectious diseases differs markedly
compared with that 200 years ago. Nevertheless, ONJ has
engaged practitioners and scientists for almost 10 years now
and remained incompletely understood.
Etiology and pathology
Similarly, during the early recognition of the existence of
PNJ, there were vehement discussions about the pathologi-
cal pathway of jaw necrosis. A few scientists, like Dr. Georg
Wegner from the Institute of Pathology in Berlin, made
some important discoveries. Wegner presented different an-
imal studies about “the influence of phosphorus on the
organism” in 1872 [13] and classified two different effects
of phosphorus: an “indirect” reaction after systemic intake
of phosphorus and a “direct” reaction, whereas phosphorus
fumes had direct contact with the oral mucosa.
After direct contact of the oral mucosa of rabbits with
phosphorus fumes, Wegner found swelling of the jaws with
collateral infection and indicated the teeth as the origin of this
reaction. In some animals, he additionally created a small injury
of the periosteum in the jaw area. Interestingly, these animals
developed severe periostitis with necrosis of the underlying
bone after exposure to phosphorus fumes. This is very similar
to recent animal studies by Sonis et al. and others, in which
Fig. 1 A male patient with extensive osteopathology of the maxilla
associated with underlying metastasized bladder carcinoma and long-
term treatment with zoledronic acid. Detachment (double arrow) and
retraction (arrow) of the periosteum are shown clearly to the extent of
the infraorbital rim. Massive signs of progressive infection with previ-
ous loss of parts of the maxilla are present
Fig. 2 a A 21-year-old female match factory worker, 5 months after
mandibulectomy because of PNJ of the entire mandible. b A photo-
graph of the resected mandible shows the typical clinical appearance,
similar to BRONJ with persistent sockets and no signs of remodeling
Fig. 3 a A female patient with BRONJ in the left mandibular molar
area. After a drug holiday of about 6 months, demarcation of necrotic
bone could be found. b For surgical treatment, subsequent sequestrec-
tomy and local revision of surrounding bone have been performed.
Complete remission could be achieved
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ONJ-like areas were found after extraction of teeth in rats
treated with zoledronic acid [14, 15]. Wegner highlighted the
importance of direct contact of phosphorus with the periosteum.
In a second experiment, Wegner described the indirect
reaction as follows: “in all areas where usually bone marrow
structure develop, a tissue is present, which looks as cortex of
the long bones—absolutely solid and compact all over” [13].
The excess mass was formed at the expense of the volume of
vessels in the Haversian canals, possibly leading to necrosis of
bone. On the basis of those experiments, the idea of possible
intake of phosphorus into the bone was born, and phosphorus
was administered for the treatment of diseases with “weak
bone development” with questionable success—as a progen-
itor of later bisphosphonate therapy.
von Schulthess-Rechberg described the pathological–ana-
tomical pathway of PNJ as follows: “specifically acting sub-
stances reach the periosteum due to local factors. It inflames,
thickens, and is detached from the bone. At the same time,
periosteal reaction starts with formation of osteophytes. The
infection progresses and affects Haversian canals with osteo-
cytes and subsequent necrosis of bone” [11].
Different hypotheses about the pathological pathway of
ONJ have been proposed, as for example, avascular necro-
sis, genetic influence, direct soft tissue toxicity, or impaired
bone remodeling [16, 17]. Interestingly, despite initial op-
position, there seems to be a tendency towards acknowledg-
ment of a major role of infection [18–21]. The important
role of the detached retracted and thickened periosteum in
patients with ONJ has been clearly demonstrated clinically
and remains to be investigated.
Risk factors
Many different match production workflows had to be per-
formed. Some were highly injurious to health, depending on
the type and duration of contact to white phosphorus, as there
were the dunkers, mixers, and boxers who packed the
phosphorus-covered matches into boxes. Interestingly, one
characteristic of patients with PNJ, which differed from other
types of jaw necrosis, was the “delayed occurrence” of this
disease with an average of about 5 years after the start of
phosphorus fume exposure [11, 22]. This fact led to the
hypothesis of accumulation of phosphorus in the bone at that
time [4]—corresponding to the cumulative dose of bisphosph-
onate as one of the recognized risk factors for ONJ today [2].
Local risk factors (e.g., carious teeth and extraction sockets)
were one of the most discussed local factors [22]. Hirt reported
an about threefold higher risk of development of PNJ in work-
ers with “poor” teeth [22]. Contact of phosphorous with the
periosteum was assumed to lead to the development of PNJ.
Local risk factors are acknowledged triggers of the devel-
opment of ONJ, including dental infection, dental implants,
and ill-fitting dentures. Any factor that involves possible
contact with the bone or periosteum of the oral cavity is a
possible source of osteopathology, as was the case 200 years
ago [23]. In contrast to other authors, spontaneous osteopa-
thology was not found in this ONJ patient collective [1].
Clinical picture
Examination of ONJ reveals striking parallels. In 1847, von
Bibra and Geist presented a classification of the different
courses of PNJ (Table 2) [24]. A similar staging system for
ONJ was published and updated in 2009 by the American
Association of Oral and Maxillofacial Surgery [2].
Geist specifically mentioned the difficulty of diagnosis of
first-stage phossy jaw, because there was no difference
between patients with common dental pain. Non-exposed
bone but apparent osteopathology of the jaws was a frequent
finding in our ONJ patient group too (24 %) and has also
been described by other authors [25].
Treatment
According to von Schulthess-Rechberg, three main strate-
gies were developed during the first years of dealing with
PNJ, with interesting parallels to the therapeutic strategies
Table 2 Staging system for PNJ presented from von Bibra and Geist in 1847 and staging system for BRONJ presented by the AAOMS in 2009
Stadium I (stadium morbid primum–stadium invasionis): Beginning of disease with intermittent dental pain and gingival swelling, but the patient is healthy
Stadium II (Stadium morbi secundum: Stadium reactionis primum): Time span from the occurrence of symptoms until the exposure of bone.
Patients presented with swelling, pain, and other signs of infection
Stadium III (stadium reactionis secundum): Time span from bone exposure until rejection of necrotic bone
Stage 0: No clinical evidence of necrotic bone, but there are nonspecific clinical findings and symptoms
Stage 1: Exposed and necrotic bone in asymptomatic patients without evidence of infection
Stage 2: Exposed and necrotic bone associated with infection as evidenced by pain and erythema in the region of the exposed bone with or without
purulent drainage
Stage 3: Exposed and necrotic bone in patients with pain, infection, and one or more of the following: exposed and necrotic bone extending beyond
the region of alveolar bone (i.e., inferior border and ramus in the mandible, maxillary sinus, and zygoma in the maxilla) resulting in pathologic
fracture, extraoral fistula, oral antral/oral nasal communication, or osteolysis extending to the inferior border of the mandible of sinus floor
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used in BRONJ, bearing in mind that antibiotic therapy was
not available back then.
1. Immediate prevention of progression with exposure
prevention and careful intraoral “disinfection” (potassi-
um iodine rinse)
2. Abscess drainage, removal of insufficient teeth, and
surgical therapy, if necessary
3. Systemic antiphlogistic treatment
Symptoms, especially pain, were usually resolved with
these methods—even before the actual surgical treatment
[11]—similar to today’s resolution of BRONJ symptoms
after the start of antibiotic treatment.
Two main surgical strategies have been described in
about 1850. One group advocated early and radical removal
of both affected and parts of healthy bone to prevent inva-
sion and systemic proliferation. Another group of surgeons
favored surgical restraint until demarcation of sequestrum
with subsequent removal and revision of the surrounding
bone. This “wait and see” strategy took an average of 1 to
2 years until complete loosening of the sequestrum [11]. The
objective of this strategy was to preserve the periosteum,
because of “osteoplastic capabilities” with the aim of regen-
erating the jawbone. One of the main advocators of this
technique was von Langenbeck in Berlin with his students
Billroth and Thiersch, who made an effort in operating his
patients through creating incisions in the oral cavity instead
of having them in the face [11]. The main surgical doctrine
after a few years of dealing with PNJ became avoidance of
primary resection; this resulted in a decrease of mortality
rate to about 18 to 25 % [11, 26].
These strategies are again applied today for the treatment
of ONJ. Immediate radical resection has shown to be
restricting for the patient and did not always result in the
expected remission, whereas conservative treatment leads to
frequent recurrent symptomatic infections [27]. Therefore,
the author’s therapy strategy for BRONJ patients changed
during the last years. Drug holidays prior to surgical treat-
ment were established; this resulted in rapid sequestrum
formation similar to PNJ, followed by sequestrectomy, ex-
tensive rinsing with antibiotic solution, and revision of the
surrounding bone. With this strategy, satisfactory rates of
complete remissions could be achieved with a minimal
invasive approach and without restriction of the patients’
quality of life.
Prevention
By 1846, prophylactic measures for prevention of PNJ (e.g.,
frequent facial and oral washing, ventilation, strict separa-
tion of work and break rooms, restricted working hours, and
ban of child labor) had been enacted [28]. At that time,
corpsmen were responsible for assuring its implementation
in match factories. Restrictions in Zurich also included a
prohibition against hiring workers with carious teeth or any
type of bone diseases. Each match factory worker under-
went monthly clinical and dental examinations by the re-
gional specialist [11, 28].
Similar measures adapted to present times are included in
several guidelines for patients undergoing therapy with bone
resorption inhibitors. These measures include eradication of
all possible infectious sources before the start of drug ther-
apy and frequent dental examinations. Similar to a reported
decrease of PNJ after implementation of preventive meas-
ures, prevention of ONJ also seems to have shown success
[29–31]. This fact again emphasizes the impact of local risk
factors such as dental infection or peri-implantitis. This
article provides an interesting historical insight into medical
and surgical profession in the nineteenth century with strik-
ing parallels of ideas and much “repetition” in the approach
to a new disease.
Osteopathology of the jaws associated with phosphorus
or bone resorption inhibitors is an excellent example of
“learning from the past.” The increasing tendency of
approaching BRONJ as a “special entity of osteomyelitis”
in a pretreated and metabolically different bone could have
been adopted from specialists in the nineteenth century, just
like the minimally invasive surgical approach. Perhaps, one
will soon uncover the periosteum pathophysiologically as
the main triggering anatomical structure for bony exposure.
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